Why the study?
Several echocardiographic techniques are used to diagnose HFPEF, and this study aimed to examine the use of left atrial ejection force as a measure for its diagnosis.
Does left atrial ejection force (LAEF) differ between patients with heart failure with preserved ejection fraction (HFPEF) and healthy controls?
Does left atrial ejection force (LAEF) differ between patients with heart failure with preserved ejection fraction (HFPEF) and healthy controls?
Left atrial ejection force is significantly elevated in patients with HFPEF and may serve as a useful adjunctive echocardiographic marker for its diagnosis, including in patients with borderline diagnostic scores.
LAEF may aid HFpEF diagnosis; leaves open incremental value over HFA-PEFF in broader cohorts.
Introduction: Several echocardiographic techniques are used to diagnose heart failure with preserved ejection fraction (HFPEF). Left atrial ejection force (LAEF) is a measure of left atrial (LA) systolic function. The aim of this study was to examine the use of LAEF as a measure for the diagnosis of HFPEF. Methods: A prospective study including 100 patients with HFPEF and 100 healthy controls. Heart failure association algorithm score for the diagnosis of HFPEF (HFA–PEFF score) and N-terminal pro-brain natriuretic peptide (NT-pro-BNP) were assessed. Transthoracic echocardiography measured indexed left ventricular mass index (LVMI), left ventricular (LV) ejection fraction, LA volume index (LAVI), global longitudinal strain (GLS), trans-mitral Doppler velocities, E/A ratio, E/e' ratio, and estimation of LAEF. Results: Patients in the HFPEF group were more frequently hypertensive, diabetic, and had a history of ischemic heart disease. NT-pro-BNP was higher in the HFPEF group (P < 0.0001). LVMI, relative wall thickness, and LAVI were all significantly higher in the HFpEF group (P < 0.0001 for all). LV-GLS was significantly lower in the HFPEF (P < 0.0001). LAEF was significantly higher in the study group 142.14 ± 24.27 versus 92.18% ±13.99% (P < 0.0001). A sub-group of 18 patients in the study group with a borderline HFA-PEF score of 4 had a LAEF that was significantly higher than the control group (P < 0.0001) but did not differ from the rest of the HFPEFF group patients. Conclusion: LAEF was significantly higher in patients with HFPEF compared to healthy controls. Patients with a borderline HFA-PEFF score of 4 had a significantly higher LAEF as compared to controls.
No takes yet. Share an insight, caveat, or question.
Missiri et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: